**Core tip:** We present a patient with focal nodular hyperplasia (FNH) of the liver who was followed up for 7 years. A 26-year-old woman with a 5-year history of oral contraceptive use was referred to our hospital in February 2005 for further examination of a liver tumour. The diagnosis of FNH was made using magnetic resonance (MR) imaging with hepatospecific contrast media. After 7-year from the diagnosis, we observed the complete spontaneous regression of the lesion by enhanced MR scanning. In this patient, discontinuation of oral contraceptive use and two childbirths may have influenced the natural history of FNH.

INTRODUCTION
============

Focal nodular hyperplasia (FNH) is a benign hepatic lesion common in young women; a localized increase in arterial blood flow produced by a vascular abnormality may be involved in the pathogenesis of FNH\[[@B1]\].

The natural history of FNH is still unknown, because long-term follow-up studies of histologically proven FNH have been performed only in small series of patients, with conflicting results\[[@B2]-[@B6]\].

Surgery or interventional radiology treatment are not recommended, except in few cases when the tumour compresses neighbouring organs, liver vessels or bile ducts\[[@B7]\].

We report a patient with giant FNH of the liver, in whom the complete spontaneous regression of the lesion was observed on enhanced magnetic resonance with hepatobiliary phase, after a 7-year period of observation.

CASE REPORT
===========

A 26-year-old woman was referred to our centre in February 2005 with an incidentally detected liver lesion on an abdominal ultrasound done as part of the imaging work-up for mild abdominal pain. No relevant past medical or surgical history was elicited. The patient was on the oral contraceptive pill for the past five years. Physical examination and a routine biochemical liver screen were unremarkable.

Further imaging was performed by magnetic resonance imaging (MRI), using a hepatospecific contrast agent (Gd-BOPTA, MultiHance, Bracco Imaging, Milan, Italy). This showed a 11.5 cm T1 and T2 isointense mass lesion in the right liver lobe, with small central scar, mosaic arterial enhancement, iso to hypoenhancement to liver on the delayed venous phases, and uptake of Gd-BOPTA on the hepatobiliary phase at two hours post contrast administration (Figure [1A](#F1){ref-type="fig"}-C). These findings were considered pathognomonic for FNH, and a biopsy was therefore deemed unnecessary\[[@B8]-[@B10]\].

![Magnetic resonance imaging showing a typical large focal nodular hyperplasia in 2005 (A-C) with complete spontaneous regression after 7 years of follow-up (D-F). Gd-BOPTA-enhanced magnetic resonance imaging showed a large hypervascular lesion on arterial phase imaging (A), with iso to hypoenhancement on the delayed venous phase (B), and uptake of Gd-BOPTA on the 2 h delayed hepatobiliary phase (C). Note the central scar inside the lesion (white arrow). In 2012, MRI with the same contrastographic sequences demonstrated complete resolution (D-F), with residual subcentimeter scarring (red arrow).](WJG-22-10461-g001){#F1}

The patient discontinued the oral contraceptive pill soon after diagnosis. She had two successful gestations (in 2006 and 2010). A follow-up Gd-BOPTA enhanced MRI performed in January 2012 showed complete involution of the known FNH (Figure [1D](#F1){ref-type="fig"}-F), except for a subcentimetre hypointense area that was attributed to residual scarring. At present, the patient remains asymptomatic and is doing well.

DISCUSSION
==========

FNH of the liver is a benign condition occurring in 0.6%-3% of the general population. Most lesions are diagnosed incidentally and the natural history of the disease remains largely unknown. It has been postulated that a localized increase in arterial blood flow produced by a pre-existing vascular abnormality may be involved in the pathogenesis of FNH, through an exaggerated hyperplastic response\[[@B1]\]. FNH is the second commonest benign lesion of the liver following hemangioma\[[@B11]\] and FNH nodules are well-circumscribed unencapsulated nodules composed of hyperplastic hepatocytes surrounded by fibrous bands radiating from a central fibrotic scar containing thick-walled arteries\[[@B1],[@B11]\].

The natural history of FNH is still unknown, because long-term follow-up studies of histologically proven FNH have been performed only in small cohort of patients, with conflicting results\[[@B2]-[@B6]\]. Surgical or interventional radiological treatment is usually not advocated, except in the rare exceptional cases where large FNH compress neighbouring organs, liver vessels or bile ducts\[[@B7]\].

The non-invasive diagnosis of FNH was quite challenging prior to the introduction of MRI performed using hepatospecific contrast agents. The typical MR imaging features of FNH include the presence of a central scar, arterial enhancement, and sustained enhancement in the venous phases. FNH usually shows iso to slightly hypointensity on T1 and iso to slightly hyperintensity on T2 weighted images. FNH nodules appear as bright, or brighter, than normal liver parenchyma on the hepatobiliary phase of MRI performed with such agents\[[@B8]-[@B10]\], avoiding the need for imaging-guided biopsy.

The pathogenesis and natural history of FNH remain largely unknown\[[@B1]-[@B6]\]. A possible aetiological link to endogenous oestrogens has been considered given the female predominance and peak incidence during childbearing years\[[@B1]\]. Exogenous oestrogens might also promote growth and marked vascular changes in FNH, and are usually discontinued in patients with FNH\[[@B12]-[@B14]\]. Regression has been reported following withdrawal of the oral contraceptive pill\[[@B13]-[@B15]\]. To our knowledge, in the English literature there is no report illustrating a complete regression of giant FNH but only studies of decreasing in size. The available data is limited and conflicting, with some studies reporting that neither the size nor the number of FNH lesions were influenced by oral contraceptive use\[[@B3],[@B4]\] and that pregnancy was also not associated with FNH changes or complications\[[@B16]\].

Therefore, the relationship between low-dose oestrogen, pregnancy and FNH remains controversial. In our patient, discontinuation of oral contraceptive use and two childbirths may have influenced the natural history of FNH. The present case suggests that asymptomatic FNH could be managed conservatively with discontinuation of the oral contraceptive pill, since this might promote spontaneous regression.

COMMENTS
========

Case characteristics
--------------------

The authors report a patient with giant focal nodular hyperplasia (FNH) of the liver, in whom the complete spontaneous regression of the lesion was observed on enhanced magnetic resonance with hepatobiliary phase, after a 7-year period of observation.

Clinical diagnosis
------------------

The patient remained asymptomatic and was doing well.

Differential diagnosis
----------------------

No differential diagnosis.

Laboratory diagnosis
--------------------

All labs were within normal limits.

Imaging diagnosis
-----------------

A follow-up Gd-BOPTA enhanced magnetic resonance imaging (MRI) showed complete involution of the known FNH, except for a subcentimetre hypointense area that was attributed to residual scarring.

Pathological diagnosis
----------------------

No pathological diagnosis.

Treatment
---------

Discontinuation of the oral contraceptive pill.

Related reports
---------------

Regression of FNH has been reported following withdrawal of the oral contraceptive pill. To our knowledge, in the English literature there is no report illustrating a complete regression of giant FNH but only studies of decreasing in size. In our patient, discontinuation of oral contraceptive use and two childbirths may have influenced the natural history of FNH.

Term explanation
----------------

FNH of the liver is a benign lesion occurring in 0.6%-3% of the general population that probably reflects a local hyperplastic response of hepatocytes to a vascular abnormality.

Experiences and lessons
-----------------------

The present case suggests that asymptomatic FNH could be managed conservatively with discontinuation of the oral contraceptive pill, since this might promote spontaneous regression.

Peer-review
-----------

This manuscript is well-written and easy for readers to follow. It highlights the possibility that discontinuation of oral contraceptive pill and two childbirths may influence the lesion's regression. The hepatospecific contrast media used in MRI to clearly diagnose FNH is Gd-BOPTA. Overall, this paper can help improve readers' clinical practice.
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